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Normal wound healing is a complex, highly regulated
dynamic process that requires co-ordinate responses of
both epidermal and dermal compartments. To accom-
plish the healing process several growth factors, chemo-
kines, and matrix elements signal both cell proliferation
and migration during the in£ammatory and reparative
phases and limit these responses during the remodeling
phase. We have found that the Glu-Leu-Arg-negative
CXC chemokines interferon c inducible protein 10,
monokine induced by interferon c, and platelet factor
4, limit ¢broblast responsiveness to growth factors, but
the functioning of these factors in wound healing re-
mains uncertain. We hypothesized that the keratino-
cyte-derived member of this Glu-Leu-Arg-negative
CXC family, interferon c inducible protein 9 (IP-9)
CXCL11 (also known as I-TAC, b-R1, and H-174) signals
to the dermal compartment to synchronize the re-
epithelialization process. Interferon c inducible protein
9 was produced after mechanical wounding of a kerati-
nocyte monolayer, suggesting for the ¢rst time that this
could be a wound response factor. Interferon c inducible
protein 9 limited epidermal growth factor (EGF)-in-
duced ¢broblast motility (5777%) by the same protein
kinase A (KA)-mediated inhibition of calpain activa-
tion and cell de-adhesion as described for interferon c
inducible protein 10. Surprisingly, interferon c inducible
protein 9 enhanced growth factor-induced motility in
undi¡erentiated keratinocytes (137719%) as determined
in a two-dimensional in vitro wound healing assay, and
interferon c inducible protein 9 alone promoted moti-
lity in undi¡erentiated keratinocytes (49710% of epi-
dermal growth factor-induced motility). A stimulated
keratinocyte/target cell coculture system revealed that
interferon c inducible protein 9 acts as a soluble kerati-
nocyte-derived paracrine factor for both ¢broblasts and
keratinocytes. Further, we found that in both ¢broblasts
and undi¡erentiated keratinocytes, interferon c induci-
ble protein 9 exerted its action through modulation of a
cytosolic protease, calpain. Interestingly, interferon c
inducible protein 9 increased calpain activity in undif-
ferentiated keratinocytes, whereas the same chemokine
inhibited the calpain activity in ¢broblasts. This pro-
vides for a model whereby redi¡erentiated basal kerati-
nocytes could limit ¢broblast repopulation of the
dermis underlying healed wounds while simultaneously
promoting re-epithelialization of the remaining provi-
sional wound. Key words: cell motility/CXC chemokines/
epidermal growth factor receptor/calpain/wound healing. J In-
vest Dermatol 120:1110 ^1117, 2003
W
ound healing is a complex process of tissue de-
position and remodeling resulting in the re-
generation of an intact skin barrier and
functional organ (Gailit and Clark, 1994; Tho-
mas et al, 1995). The complexity of this process
is accentuated by the fact that skin is comprised of two distinct
compartments, the ectodermally derived epithelial epidermis
and the mesodermally derived mesenchymal dermis, which are
separated by a basement membrane barrier. To regenerate this
organ, numerous cellular, hormonal, matrix, and enzymatic ac-
tivities in each compartment are required to act in a co-ordinated
manner with the other compartment. Whereas precise mechan-
isms are unde¢ned, a generalized picture has emerged. Healing
of skin has two important but distinct aspects, ¢broplasia and
epithelialization. Closure of a wound requires ¢broblast prolifera-
tion and migration into granulation tissue, followed by sequential
depositions of speci¢c matrix components, and ¢nally contrac-
tion and remodeling. The epidermal barrier must be re-estab-
lished by proliferation and migration of keratinocytes over the
denuded area, followed by di¡erentiation. Both closure and
epithelialization are required to restore physical integrity of the
skin and prevent untoward sequelae, chie£y infection. Data are
emerging that demonstrate that these two processes are tempo-
rally linked; in some human wounds if keratinocytes fail to re-
epithelialize, the underlying dermis remains in a granulation
tissue state (Ja¡e et al, 1999). This communication is thought
to be critical for preparing the wound bed for remodeling and
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maturation, thus prevent excess scarring. Whereas it remains
unknown how the epidermis and dermis co-ordinate their
respective regeneration, it has been hypothesized that select
molecules signal the status of wound healing between these two
compartments.
During the regenerative phases of wound repair, the cells of
each layer must proliferate and migrate to repopulate the nascent
wound. The basal keratinocytes undergo a transition that enables
such repopulation, whereas the provisional matrix is invaded by
¢broblasts as the ¢rst step in regenerating the future dermal layer.
The numerous growth factors present throughout repair, includ-
ing high levels of epidermal growth factor (EGF) receptor li-
gands, are thought to promote these mitogenic and motogenic
responses (Kiritsky et al, 1993; Steenfos, 1993; Wells et al, 1998;
Singer and Clark, 1999).While during the initial stages of wound
repair, ¢broblasts and keratinocytes are driven to proliferate and
migrate into the wound bed, these processes must be limited
late in wound healing to prevent ¢broplasia or excess matrix
deposition.
The transition to the remodeling phase is marked in the dermis
by cessation of the ¢broplasia response and in the epidermis by
redi¡erentiation to a strati¢ed squamous epithelium. Thus, as the
basement membrane is re-established behind the leading edge of
re-epithelialization (Gipson et al, 1988) the keratinocytes revert to
a di¡erentiated phenotype and the underlying dermis attains the
pro¢le of nonwounded skin (Martin, 1997). As this extends deep
into the dermis, soluble factors have been suggested as the key
communicators to the ¢broblasts that the epidermis has been re-
established. Whereas the signals that trigger this maturation are
still not fully deciphered, the ELR (Glu-Leu-Arg)-negative
CXC chemokines have been shown to be capable of inhibiting
¢broblast motility by preventing rear de-adhesion (Shiraha et al,
1999) and thereby converting movement to matrix contraction
(Allen et al, 2002). One of these chemokines, interferon g induci-
ble protein (IP)-10 (or CXCL10) appears during this late phase,
being produced by the neovascular endothelial cells deep in the
regenerating wound bed (Engelhardt et al, 1998). A related ELR-
negative CXC chemokine, IP-9 [or b-R1 (Rani et al, 1996), H174
(Jacobs et al, 1997), I-TAC (Cole et al, 1998), or CXCL11], is pro-
duced by basal keratinocytes in response to immune-mediated
injuries (Tensen et al, 1999).We propose that this also appears dur-
ing the process of healing as a wound response factor. These
ELR-negative CXC chemokines were originally found as modu-
lators of cells of the hematopoietic lineage; however, recently,
chemokine receptors also have been found expressed and func-
tional on mesenchymal cells (Neote et al, 1994; Yue et al, 1994;
Peiper et al, 1995; Mach et al, 1999; Sauty et al, 1999; Shiraha et al,
1999; Cockwell et al, 2002; Grone et al, 2002). The ELR-negative
members of the CXC family of chemokines, all of which bind to
a common CXCR3 receptor, inhibit endothelial cell prolifera-
tion and migration (Gupta and Singh, 1994; Luster et al, 1995;
Strieter et al, 1995) and ¢broblast migration (Shiraha et al, 1999).
These appear to act dominantly over promitogenic and promoti-
lity chemokines and growth factors (Shiraha et al, 1999). Thus,
these chemokines, which signal through the same CXCR3
receptor (Farber, 1997; Baggiolini, 1998; Flier et al, 2001; Loetscher
et al, 2001; Podovan et al, 2002), are candidates to signal dermal
maturation.
As the above data suggest, the ELR-negative CXC chemokine
IP-9 would be well situated to stop the ¢broblast repopulation of
the dermal layer; however, the modulators of the keratinocyte
progression are unknown, though thought to involve cell^cell
contact inhibition (Martin, 1997). Still, due to proximity the re-
epithelializing keratinocytes would be exposed to the same fac-
tors as the dermal ¢broblasts. Thus, the question remains of
whether this molecule also a¡ects the adjacent keratinocytes that
need to proliferate and migrate over the provisional wound ma-
trix. In this study we determined that IP-9 modulates the pheno-
typic behavior of undi¡erentiated keratinocytes in a manner
opposite to its e¡ects on ¢broblasts. Surprisingly, IP-9 induces
keratinocyte migration in contradistinction to its inhibition of
¢broblast motility. Unexpectedly these diametrically opposed be-
haviors, seen in di¡erent cell types derived from distinct lineages,
were e¡ected through the same biophysical process of calpain-
regulated de-adhesion. Calpain, a ubiquitous intracellular
protease (Johnson and Guttman, 1997; Sorimachi et al, 1997; Sor-
imachi and Suzuki, 2001), is required for rear de-adhesion during
the motility of adherent cells (Glading et al, 2000; Glading et al,
2001). IP-9 elicited the same protein kinase A-mediated inhibition
of EGF-induced calpain activation as IP-10 in ¢broblasts. In un-
di¡erentiated keratinocytes, however, IP-9 activated calpain. Initi-
al studies suggest that EGF and IP-9 induce cell migration via
di¡erential usage of calpain isoforms.These ¢ndings not only ex-
plain the diametrically opposite e¡ects of the same ligand in dif-
ferent cell types and provide for contextually appropriate though
divergent cell responses but also highlight the epigenetic controls
of cell decision making during complex physiologic responses.
MATERIALS ANDMETHODS
Materials Hs68 normal human diploid ¢broblasts were purchased from
American Type Culture Collection (ATCC, Rockville, MD). Hs68 cells
were used at passages 5^12, representing PDR 21^42, prior to any
signi¢cant de¢cit due to in vitro aging (Shiraha et al, 2000). Human
neonatal foreskin epidermal keratinocytes were obtained from Cascade
Biologicals, Inc. (Portland, OR) and the cultures were used at passages
2^9. IP-9 and IP-10 were purchased from Peprotech (Rock Hill, NJ).
Recombinant human interferon (IFN)-g was obtained from R&D
Systems, Inc. (Minneapolis, MN). Human recombinant EGF was
obtained from Collaborative Biomedical Products (Bedford, MA).
Antibody against I-TAC/IP-9 was obtained from Peprotech. Calpain
inhibitor I ALLN (CI-1) was obtained from Biomol (Plymouth Meeting,
PA). Rp-8-Bromo-cyclic adenosine monophosphate was purchased from
Calbiochem (La Jolla, CA). Boc-LM-CMAC (t-butoxycarbonyl-leu-met-
chloromethylaminocoumarin) was obtained from Molecular Probes
(Eugene, OR). Mitomycin C was obtained from Sigma (St Louis, MO).
Human monokine induced by interferon g (MIG) antibody was obtained
from R&D Systems, Inc. The use of the anonymized excess tissue
specimens and human primary cells were deemed exempt by the
University of Pittsburgh IRB upon review.
Fibroblast and keratinocyte cultures Hs68 ¢broblasts were grown in
Dulbecco minimal Eagle’s medium with 10% fetal bovine serum,
1antibiotics (penicillin and streptomycin), 1nonessential amino acids,
and 1sodium pyruvate (all from Life Technologies, Rockville, MD)
(Shiraha et al, 1999). When the cells reached 80% con£uence they were
quiesced in Dulbecco minimal Eagle’s medium with 0.1% dialyzed fetal
bovine serum for 48 h; this media switch reduces cell proliferation and
thymidine incorporation over 90% while maintaining viability (Shiraha
et al, 1999). Human epidermal keratinocytes were grown in EpiLife
medium [serum free medium with human EGF (10.2 ng per ml),
hydrocortisone (0.18 mg per ml), bovine pituitary extract (0.2% v/v),
bovine insulin (5 mg per ml), and transferrin (5 mg per ml)] (Cascade
Biologicals) containing low calcium (0.06 mM) to maintain a
dedi¡erentiated, proliferative, and migratory state. This state of the
keratinocytes will be referred to as ‘‘undi¡erentiated’’ to distinguish them
from polarized keratinocytes noted upon a switch to high calcium (0.37
mM) (Eckert and Rorke, 1989; Gibson et al, 1996). Cells were quiesced in
EpiLife medium without EGF, bovine pituitary extract, and insulin for 48
h; this media switch abolishes cell proliferation while maintaining viability
(cell number at 48 h under these conditions is 9476% of that at 24 h; p is
not signi¢cant).
Keratinocyte^¢broblast cocultures Normal human neonatal foreskin
keratinocytes were seeded on a Transwell clear inserts of polyester
membrane with a 0.4 mm pore size and a diameter of 12 mm for 12-well
plates (Costar Corporation, Corning, NY). Normal human Hs68
¢broblasts were plated on the lower chambers of 12-well plastic dishes
and were grown to con£uence. After both the keratinocytes and
¢broblasts reached con£uence, the cells were quiesced in medium
containing 0.1% dialyzed serum for ¢broblasts and growth factor-
de¢cient EpiLife medium for keratinocytes. The inserts containing the
keratinocytes were transferred on to 12-well dishes with the ¢broblasts.
The keratinocytes were then stimulated with 2000 U of human IFN-g for
24 h.Two di¡erent conditions served as controls. Inserts with keratinocytes
but not treated with IFN-g and inserts without keratinocytes but treated
with IFN-g. Cell migration assay of the ¢broblasts was performed and
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photographs were taken at 0 and 24 h and the relative distance traveled
determined.
To determine the role of IP-9 in culture cross-attenuation, IP-9
production was abrogated by anti-sense phosphothiorated oligonucleo-
tides against IP-9 (TTTCAGATGCCCTTTTCCAG;Tensen et al, 1999). Cells
were seeded and cocultured as described above and quiesced. The keratino-
cytes in the quiescent media were treated with anti-sense for IP-9 for 48 h
prior to the assay. In parallel, immunoblotting for IP-9 demonstrated
that the treatment blocked IFN-induced IP-9 production.
Keratinocyte^keratinocyte cocultures Normal human neonatal
foreskin keratinocytes were seeded on both Transwell clear inserts of
polyester membrane with a 0.4 mm pore size and a diameter of 12 mm for
well plates (Costar Corporation) and also on the lower chamber of 12-well
plastic dishes and were grown to con£uence. After the cells become
con£uent on both the chambers, the cells were quiesced. The
keratinocytes in the inserts were stimulated with 2000 U of human IFN-g
for 24 h, and also in the other set the inserts were stimulated with IFN-g
for a few hours, washed, and then brought in contact with the
keratinocytes in the lower chamber and left for 24 h. Cell migration assay
of the keratinocytes were performed and photographs were taken at 0 and
24 h and the relative distance traveled determined.
Cell migration assay An ‘‘in-vitro wound’’ assay was performed in both
¢broblasts and keratinocytes. Keratinocytes (40,000 per cm2) and ¢broblasts
(30,000 per cm2) were plated in tissue culture dishes. After they reach 80%
con£uence the cells were quiesced in Dulbecco minimal Eagle’s medium
containing 0.1% dialyzed serum for ¢broblasts and growth factor
de¢cient EpiLife medium for undi¡erentiated keratinocytes for 48h prior
to being denuded by a rubber policeman at the center of the plate. EGF-
induced cell migration was assessed by the ability of the cells to move into
an acellular area in both ¢broblasts and undi¡erentiated keratinocytes
(Chen et al, 1994). The cells were then treated with or without EGF
(1 nM), IP-9 (50 ng per ml), IP-10 (50 ng per ml), and CI-1 (5 mg per ml),
and incubated at 371C for 24 h; these concentrations were determined
empirically to provide either maximum motility or inhibition without
toxicity (Shiraha et al, 1999; Glading et al, 2000). Photographs were taken
at 0 and between 23 and 24 h, and the relative distance traveled by the
cells at the acellular front was determined by computer-assisted image
analysis; markings on the plate ensured measurement of the same site for
the photographs. The residual gap between the migrating ¢broblasts and
keratinocytes was measured and expressed as a percentage of the area of
the wound remaining un¢lled as normalized to EGF-induced ‘‘healing’’ of
the wound. We examined cells at 40-fold magni¢cation, one ¢eld
(approximately 60^70 cells) with three measurements in each ¢eld, each
experiment performed in duplicate or triplicate as mentioned. To con¢rm
that cell proliferation was not confounding analyses (Chen et al, 1994),
mitomycin C (0.5 mg per ml) was added at the time of wounding;
the results of the 24 h motility assay were indistinguishable in the
presence or absence of mitomycin C (data not shown). The continuous
inclusion of mitomycin C (0.5 mg per ml) prevents cell proliferation in
¢broblasts (Chen et al, 1994) and keratinocytes. For the undi¡erentiated
keratinocytes the addition of mitomycin C to the quiescent media
had no appreciable e¡ect as there is no demonstrable increase in cell
number for the 24 h period of the assay (9876% of the cells at 48 h
compared with 24 h); in complete media where the cell number increases
over this period, mitomycin C reduced the increase in cell number
down to 1577% of the increased number in the absence of mitomycin C
(a reduction of 85%).
Immunoblotting procedures IP-9 production was stimulated by
creating multiple cross-hatched ‘‘wounds’’ in a monolayer of undif-
ferentiated keratinocytes. Cells were lyzed at various times (0 h, 2 h, 6 h,
24 h, 48 h) after wounding with a rubber policeman. IFN-g stimulated
cells served as the positive control (Tensen et al, 1999). Cell lysates were
separated on 18% sodium dodecyl sulfate^polyacrylamide gel
electrophoresis and transferred to a PVDF membrane (Immobilon-P,
Millipore, Bedford, MA). Blots were probed with anti-human I-TAC/IP-9
(Peprotech) and then incubated with an alkaline phosphatase secondary
antibody followed by development with the NBT/BCIP substrate
(Promega, Madison, WI). EGF (10 nM), platelet-derived growth factor
(10 mg per ml), IP-9 (50 ng per ml), and IP-10 (50 ng per ml) were also
tested for induction of IP-9 in undi¡erentiated and di¡erentiated
keratinocytes.
Similarly, cells treated with IFN-g and with anti-sense oligonucleotides
against IP-9 were lysed after 6 h and 24 h and were separated on 18% for
IP-9 and 15% for MIG, probed for I-TAC/IP-9 and MIG. Blots were
incubated and developed as described above.
Calpain activity assays The calpain activity in individual living cells
was detected by using a Boc-LM-CMAC assay for in vivo proteolysis
(Glading et al, 2000). In brief, keratinocytes and ¢broblasts were plated on
glass coverslips. The cells were quiesced when at 50% con£uence for 48 h
and then treated in the presence or absence of IP-9, CI-1, and/or EGF for 2
h, 1 h, 30 min, and 10 min, respectively. All cells were loaded with Boc-
LM-CMAC for 20 min prior to mounting on glass slides. The treated and
control cells were then observed for CMAC £uorescence using an
Olympus £uorescent microscope (model: BX40, ¢lter: Olympus M-
NUA). Representative images of each slide were captured using a SPOTII
CCD camera. (Nikon, Inc, New York, NY, USA). The image exposure
settings were identical within each experiment (i.e., for no EGF and EGF
treatment) but did vary slightly between experiments; thus, one can
directly compare £uorescence intensity within an experiment but not
between experiments. Images shown are representative of three or more
separate experiments.
Adhesion assay Cell substratum adhesiveness of ¢broblasts and
undi¡erentiated keratinocytes were quantitated using an inverted
centrifugation detachment assay. Cells were plated at the concentration of
105 cells per ml in a 12-well plate. Cells were quiesced for 24 h and then
incubated with IP-9, CI-1, or EGF for 4 h, 30 min, or 10 min, respectively.
Wells were completely ¢lled with Dulbecco minimal Eagle’s medium and
EpiLife media, respectively, supplemented with 1% bovine serum albumin
and 25 mM HEPES (pH 7.4), and then sealed with enzyme-linked
immunosorbent assay sealing tape (Corning, Cambridge, MA) and
centrifuged inverted for 10 min at 2920 g at 371C using a Beckman
CS6R plate centrifuge; (Beckmen Coulter Inc, Fullerton, CA) 2920 g
was chosen empirically as the force required to detach approximately half
of the EGF-treated cells. Before and after the centrifugation, the number of
cells on the plates was counted by phase-contrast microscopy.
RESULTS
IP-9 is expressed in response to ‘‘wounding’’ a keratinocyte
monolayer We hypothesize that IP-9 could be a ‘‘wound
response’’ protein. If this is the case, then keratinocytes would be
expected to produce IP-9 when wounded, although it is possible
that IP-9 occurs secondary to cytokines generated during the
in£ammatory phase; this latter possibility would not minimize
the role of IP-9 in repair but would have implications for the
biology of wound repair and potential therapeutic interventions.
Interestingly, IP-9 production could be stimulated by mechanical
wounding of a monolayer of keratinocytes (Fig 1). IP-9 was not
induced by EGF, platelet-derived growth factor, or IP-10 (data
not shown). These ¢ndings prove that IP-9 could be stimulated
secondary to mechanical wounding per se, or autocrine factors
released from wounded keratinocytes.
IP-9 limits EGF receptor-mediated calpain activity and
motility in human ¢broblasts The expression of IP-9 by
wounded keratinocytes prompted us to study the e¡ect of this
ELR-negative CXC chemokine on the major cell types in
the epidermal and dermal compartments. Both ¢broblasts
and keratinocytes migrate and proliferate during dermal and
Figure1. IP-9 is a wound response factor. IP-9 is induced by a me-
chanical wounding keratinocyte (undi¡erentiated) monolayer. Keratino-
cytes were grown to con£uence in a six-well tissue culture plate and kept
in low calcium media. Multiple cross-hatched ‘‘wounds’’ were created with
a rubber policeman to a¡ect a small percentage of the cells on the plate
(o 5%). Cells were lyzed at di¡erent times and analyzed by immunoblot
using an IP-9 speci¢c antibody. IP-9 production in vitro after wounding in-
creases by 2 h and reaching peak at about 6 h and gradually decreasing by
48 h. Lane 1 represents the production of IP-9 after stimulation with IFN-g.
Shown is a representative immunoblot of three experiments.
1112 SATISH ETAL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
epidermal regeneration. As IP-9 shares the same CXCR3
receptor as IP-10 (Farber, 1997; Baggiolini, 1998) it was not
surprising that IP-9 limited EGF-induced motility (to 5777%;
po0.05) similarly to IP-10 (to 4578%; po0.05 compared with
EGF alone; p¼ not signi¢cant between IP-9 and IP-10
inhibition of EGF-induced motility) (Fig 2a) (Shiraha et al,
1999). The basal, haptokinetic motility of the ¢broblasts was
unchanged by either chemokine. This inhibition of EGF-
induced ¢broblast migration was e¡ected through a cyclic
adenosine monophosphate/protein kinase A signaling pathway
(Shiraha et al, 2002) as Rp-8Br-cyclic adenosine mono-
phosphate blocked the inhibitory e¡ect (Fig 2b). In addition,
EGF-induced ¢broblast proliferation was not a¡ected by IP-9,
similar to IP-10 (Shiraha et al, 1999) (data not shown). IP-9 also
inhibited EGF-induced calpain activity (to 2575%; po0.05)
(Fig 2c). These data suggest that IP-9 functions similarly to IP-10
in preventing ¢broblast migration (Shiraha et al, 1999).
EGF-induced ¢broblast migration is blocked by
keratinocyte-produced IP-9 From the foregoing data we
predicted that keratinocytes limit ¢broblast motility secondary
to IP-9 acting as a soluble paracrine factor. This was tested
in vitro by a Transwell coculture-based wound assay.
Keratinocytes in the inserts were exposed to IFN-g (2000 U) to
stimulate IP-9 production; IFN-g was added to empty inserts as a
control. EGF-induced migration of the human dermal ¢broblasts
was diminished in the wells in which the keratinocytes were
treated with IFN-g (Fig 3a); IFN-g alone had no e¡ect on
¢broblast migration. To ascertain that this abrogation of motility
was due to IP-9 we prevented IFN-g-induced IP-9 production
using anti-sense oligonucleotides. In the face of anti-sense
blockade of IP-9, IFN-g treatment of keratinocytes had no e¡ect
on ¢broblast cell motility (Fig 3b). IFN-g-induced IP-9
production was blocked by anti-sense oligonucleotides to IP-9
(Fig 3c). Anti-sense to IP-9 alone did not signi¢cantly a¡ect
either basal or EGF-stimulated motility; with the sense control
oligonucleotide having no e¡ect on motility (Fig 3b). The anti-
sense oligonucleotide was speci¢c for blocking IP-9 production,
as production of a related IFN-g-induced protein, Mig, was
una¡ected by either sense or anti-sense oligonucleotides to IP-9
(Fig 3d). That Mig production had no e¡ect on ¢broblast
migration is likely due to the fact that it is only weakly
produced and is detectable only after extended time periods,
whereas IP-9 is rapidly and robustly produced in response to
IFN-g. These ¢ndings strongly support a paracrine model of
cross-attenuation of stromal cell motility by epithelial-derived
factors.
IP-9 promotes cell migration and calpain activity in
undi¡erentiated human keratinocytes The suppression of
motility in ¢broblasts underlying basal keratinocytes would
signal a switch from wound repair to dermal remodeling;
however, the adjacent keratinocytes need to migrate to re-
epithelialize the wound. Therefore, we determined whether
undi¡erentiated keratinocytes were similarly inhibited by IP-9.
Surprisingly, IP-9 not only enhanced EGF-induced motility (to
137719%; po0.05) and calpain activity but actually promoted
motility (51711%; po0.05 compared with no treatment) and
calpain activity by itself (Fig 4a,b). The concentration used
provided maximal motility stimulation, with half maximal
being at approximately 25 ng per ml IP-9 promoting motility at
E 20% of the EGF-induced maximal level. Even at these lower
IP-9 concentration, the motility e¡ect appears additive to that of
EGF (10 ng per ml IP-94112710%; 25 ng per ml 4137717%;
50 ng per ml 4155715%). As expected, IP-10 acted similarly to
promote motility (61717%) and enhance the EGF-induced
response (157730%) (p40.10 between IP-9 and IP-10
treatments). These data suggested that the CXCR3 signaling
pathways were fundamentally di¡erent between the two cell
types.
IP-9 induces keratinocytes migration in a paracrine
fashion To further assess whether the increase in cell migration
in keratinocytes by IP-9 may be physiologically relevant we
employed the coculture system. We could induce keratinocyte
motility when a separate keratinocyte monolayer was treated
with IFN-g (Fig 5). This occurred even when the keratinocytes
in the insert were exposed to IFN-g in a distant culture dish and
Figure 2. IP-9 and IP-10 inhibit EGF-induced cell migration (a,b)
and calpain activation (c) in dermal ¢broblasts. (a,b) Early passage hu-
man dermal ¢broblasts were tested for motility in an in vitro wound heal-
ing assay. Cells were treated with EGF (1 nM) or IP-9 (50 ng per ml)
throughout the assay; Rp-8Br-cyclic adenosine monophosphate (50 mM)
was also present throughout. The values are shown as the ratio of the
EGF (1 nM)-induced cell motility. (c) BOC £uorescence was determined
after treatment with EGF (1 nM) for 10 min or IP-9 (50 ng per ml) for 120
min. The times were chosen empirically for maximal £uorescence (in the
case of IP-9, this was determined based on undi¡erentiated keratinocytes,
see below); CI-I (5 mg per ml) was added 30 min prior to ligand.The values
are mean7SEM of six independent studies each performed in triplicate for
motility or three experiments for calpain activation. Statistical analysis was
performed by Student’s t test.
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washed prior to generating the coculture (data not shown). That
the motility was slightly if not statistically signi¢cantly higher in
the IFN-g-treated than the IP-9-treated cells might be due to
proper presentation of ligand, avoiding the problems of receptor
desensitization due to an initial bolus. Anti-sense oligonucleotide
abrogation of IP-9 prevented the paracrine induction of
keratinocyte motility (Fig 5). The anti-sense oligonucleotides
actually reduced cell motility below baseline, which may re£ect
a basal level of IP-9 generation promoting cell motility.Whatever
the reason for this, the important result is that the paracrine
signaling is dependent on IP-9 production.
IP-9 induces keratinocyte motility via a calpain-dependent
process The activation of calpain by IP-9 in undi¡erentiated
keratinocytes would be predicted to increase motility
(Huttenlocher et al, 1997; Palecek et al, 1998); however, this
needed to be tested directly. Inhibition of calpain by CI-1 (5 mg
per ml) prevented induction of motility by either EGF or IP-9 in
undi¡erentiated keratinocytes (Fig 6). This inhibitor also
abrogated calpain activity triggered by IP-9 (Fig 4).
IP-9, via calpain, controls ¢broblast and keratinocyte de-
adhesion Calpain activity is required for lessening the
adhesion of cells to substratum to enable productive motility
(Huttenlocher et al, 1997; Glading et al, 2000). If IP-9 is acting
via calpain then de-adhesion should be modulated in the
two major cell types. Using an inverted centrifugation assay,
which enables the detection of altered adhesiveness of even
tightly adherent cells (Shiraha et al, 1999; Glading et al, 2000),
we found that either EGF or IP-9 reduced the adhesiveness
of undi¡erentiated keratinocytes (Fig 7a). At a force empirically
determined to dislodge approximately half the cells upon EGF
treatment for 30 min and IP-9 for 2 h, but few if any of
untreated cells, calpain inhibitor I prevented EGF and IP-9
induced cell de-adhesion. Interestingly, IP-9-induced de-
adhesion was additive with EGF (po0.05 compared with EGF
or IP-9 alone). In ¢broblasts IP-9 acted oppositely, abrogating
EGF-induced de-adhesion (Fig 7b) similar to IP-10 (Shiraha
et al, 1999).
Figure 3. Keratinocyte-derived IP-9 abrogates EGF-induced ¢bro-
blast motility. (a) Inserts with or without keratinocytes were treated with
IFN-g (2000 U) or EGF (1 nM) for 24 h and the ¢broblasts in the bottom
wells were tested for motility in an in vitrowound healing assay. The values
are shown as the ratio of the EGF-induced cell motility of three experi-
ments each in duplicate. (b) Fibroblast cell motility was determined by a
coculture in vitro wound healing assay in which the keratinocytes were ex-
posed to anti-sense oligonucleotides against IP-9 along with sense oligonu-
cleotides serving as controls. The values are shown as the ratio of the EGF
(1 nM)-induced cell motility of three experiments each in duplicate. Statis-
tical analyses were performed by Student’s t test for both (a) and (b).
(c) Keratinocytes were stimulated with IFN-g (2000 U) in the presence or
absence of phosphothiorated oligonucleotides (20 mM) for the designated
times. Cells were then lyzed and IP-9 production determined by immuno-
blotting. Shown is one of two determinations. (d) Keratinocytes were sti-
mulated with IFN-g (2000 U) in the presence or absence of
phosphothiorated oligonucleotides targeting IP-9 (both sense and anti-
sense 20 mM). Cells were then lyzed and immunoblotted for Mig produc-
tion.
Figure 4. IP-9 and IP-10 promote cell migration and calpain activ-
ity in undi¡erentiated keratinocytes. (a) Early passage human keratino-
cytes were tested for induced motility in an in vitro wound healing assay.
Cells were treated with EGF (1 nM) or IP-9 (50 ng per ml) throughout
the assay. The values are shown as the normalized ratio of the EGF
(1 nM)-induced cell motility of nine experiments each performed in dupli-
cate or triplicate. (b) Undi¡erentiated keratinocytes were tested for calpain
activation following stimulation by IP-9 (50 ng per ml) for 120 min or
EGF (1 nM) for 10 min by the intracellular cleavage of the synthetic sub-
strate Boc-LM-CMAC and subsequent £uorescence as shown by a repre-
sentative experiment of three.
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DISCUSSION
The aim of this study was to determine if soluble signals from
keratinocytes might be the co-ordinators of dermal and epider-
mal events during the process of wound healing.We focused on
a putative agent for this communication, the secreted soluble
ELR-negative CXC chemokine IP-9, as it activates the same re-
ceptor as IP-10 that we earlier demonstrated to abrogate EGF-in-
duced ¢broblast motility. Herein, we report that IP-9 could
indeed be a wound response factor as it is produced upon me-
chanical wounding of monolayer cultures of undi¡erentiated ker-
atinocytes. Unexpectedly, this chemokine induced opposite
behaviors for the di¡erent cell types of ¢broblasts and keratino-
cytes in promoting the motility of undi¡erentiated keratinocytes
that re£ect in vitro the in vivo phenotype of the keratinocytes
needed to re-epithelialize the wound bed. Intriguingly, this in-
duction of motility occurs via positive modulation of the same
calpain-dependent de-adhesion mechanism that IP-9 negatively
impacts in ¢broblasts. These ¢ndings provide for a model in
which the same surface receptor can e¡ect opposite behaviors in
di¡erent cell types.
Our ¢ndings explore an interesting phenomenon wherein a
chemokine inhibited cell migration in dermal ¢broblasts while
promoting migration in keratinocytes. These diametric cell re-
sponses in distinct cell lineages would be required for appropriate
wound healing. Following wound injury ¢broblasts from the
dermis (Lawrence and Diegelmann, 1994) and keratinocytes from
the epidermis enter into the wound and migrate (Singer and
Figure 5. Keratinocytes derived IP-9-induced cell migration in un-
di¡erentiated keratinocytes . (a) Inserts with keratinocytes were treated
with IFN-g (2000 U), IP-9 (50 ng per ml), or EGF (1 nM) for 24 h, and the
keratinocytes in the bottom wells were tested for motility in an in vitro
wound healing assay. IFN-g-induced motility, in the absence or presence
of EGF, was statistically no di¡erent from IP-9 treated cells; however, these
cells were more motile than the no treatment or EGF alone treated cells,
respectively (po0.05). (b) Inserts with keratinocytes were treated with
IFN-g (2000 U) in the presence or absence of phosphothiorated anti-sense
oligonucleotides against IP-9 for 24 h, and the keratinocytes in the bottom
wells were tested for motility in an in vitrowound healing assay. The values
are shown as the ratio of the EGF (1 nM)-induced cell motility of at least
two experiments each in duplicate. Statistical analysis was performed by
Student’s t test.
Figure 6. IP-9-induced cell migration requires calpain activation in
keratinocyte. Pharmacologic inhibition of calpain by CI-1 (5 mg per ml)
limited both EGF- and IP-9-induced motility in both undi¡erentiated ker-
atinocytes.The values are shown as the ratio of the EGF (1 nM)-induced cell
motility. The values are mean7SEM of six independent studies each per-
formed in triplicates. Statistical analysis was performed by Student’s t test.
Figure 7. EGF and IP-9 promote cell de-adhesion in undi¡eren-
tiated keratinocytes but IP-9 inhibits de-adhesion in ¢broblasts.
De-adhesion was performed on keratinocytes (a) or ¢broblasts (b) after
treatment with EGF (1 nM) for 30 min or IP-9 (50 ng per ml) for 120
min; CI-I (5 mg per ml) was added 30 min prior to ligand.Values are cal-
culated as percentage of precentrifugation cells remaining adherent. The
values are mean7SEM of six independent studies each performed in tri-
plicates. Statistical analysis was performed by Student’s t test.
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Clark, 1999). It is well established that re-epithelialization is
needed for proper wound repair with appropriate dermally deter-
mined tensile properties and strength. Most of this dermal rein-
forcement occurs during the remodeling phase for weeks after
re-epithelialization.The process of re-epithelialization begins within
hours of injury and eventually results in complete resurfacing. If
the keratinocytes fail to re-epithelialize, the underlying dermis
appears to remain in the granulation state (Ja¡e et al, 1999); how-
ever, for larger wounds there is a mix of wound healing phases
across the wound, i.e., the central portions may remain in the in-
£ammatory and regenerative phases even when the original mar-
gins are fully healed. This is seen as the basement membrane is
reconstituted and populated by di¡erentiated basal keratinocytes
just a few cell body lengths behind the advancing wound edge.
Fibroblasts underlying this healed margin would functionally
need to be in the remodeling phase in which migration is mini-
mized. Inhibition of rear detachment channels the motility asso-
ciated contractile forces into matrix contraction (Allen et al,
2002). The ELR-negative CXC chemokines would accomplish
this phenotypic change, with IP-10 being produced by the neo-
vascular endothelial cells (Luster et al, 1995; Strieter et al, 1995) and
IP-9 presumably from the undi¡erentiated keratinocytes (Fig 1).
That the ability of keratinocytes to modulate negatively EGF-
induced cell motility in ¢broblasts via a di¡usible factor that is
highly likely to be IP-9 (Figs 3 and 5) provides proof of principle
that such paracrine attenuation signaling exists; however, as IP-9
is soluble and di¡usible, it would reach and a¡ect the adjacent
migrating keratinocytes, which are required for re-epithelializa-
tion. Thus, one might predict that these cells would be resistant
to the anti-motility e¡ects of IP-9 mainly by lacking the receptor.
Surprisingly, these keratinocytes respond to IP-9 by increased mi-
gration. Thus, one ends up with an elegant system in which one
signal might synchronize the separate dermal and epidermal
compartments during epidermal repair.
These ¢ndings raise a number of questions, but also provide
new opportunities and tools to pursue them. Despite the caveat
that these studies have been performed ex vivo, and thus require
animal studies to con¢rm extrapolation to actual wound repair,
a number of ¢ndings are tenable. First, to the best of our knowl-
edge this is one of the ¢rst reports showing that calpain is contra-
rily modulated by the same signal, CXCL10/11 in this situation,
in di¡erent cells. As the activating cascades to the ubiquitous cal-
pain isoforms are not described, this system may provide insight.
Already, our ongoing initial studies suggest that di¡erential usage
of heterotrimer G protein isoforms might lie at the heart of the
dichotomous responses in the two di¡erent cell types, which
would be an intriguing mode of signal channeling at the im-
mediate postreceptor level. As the productive targets of calpain-
induced de-adhesion have yet to be fully deciphered, despite
numerous tantalizing hints from both in vitro and in vivo studies
(Beckerle et al, 1987; Yamaguchi et al, 1994; Carragher et al, 1999;
Glading et al, 2002), the convergence of proteolysis might aid in
future identi¢cations. Second, and still to be determined, is what
signals prevent further keratinocyte migration and induce redif-
ferentiation. Obviously from our data, the signal(s) is not the
same as for ¢broblasts. Prime candidates are matrix components/
and or contact inhibition as modulated by cell density (Wahl et al,
1992; Polk et al, 1995). Our ¢ndings of opposite e¡ects of IP-9 on
the migration of keratinocytes vs ¢broblasts highlight the pitfalls
of extrapolating ¢ndings to di¡erent cell types. Lastly, our ¢nd-
ings suggest avenues for clinical investigations. Based upon our
model of IP-9 production, which limits, at least in part, the ¢bro-
blastic response, then this signaling either may be de¢cient in
excessive scarring or may be used to limit scarring.
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